Cargando…
Epigenetic Reprogramming of Human Hepatoma Cells: A Low-Cost Option for Drug Metabolism Assessment
Autores principales: | Gailhouste, Luc, Liew, Lee Chuen, Yasukawa, Ken, Hagiwara, Keitaro, Iwazaki, Norihiko, Yamada, Yasuhiro, Hatada, Izuho, Ochiya, Takahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5904034/ https://www.ncbi.nlm.nih.gov/pubmed/29675460 http://dx.doi.org/10.1016/j.jcmgh.2017.11.006 |
Ejemplares similares
-
Epigenetic reprogramming using 5-azacytidine promotes an anti-cancer response in pancreatic adenocarcinoma cells
por: Gailhouste, Luc, et al.
Publicado: (2018) -
Differentiation Therapy by Epigenetic Reconditioning Exerts Antitumor Effects on Liver Cancer Cells
por: Gailhouste, Luc, et al.
Publicado: (2018) -
MEG3-derived miR-493-5p overcomes the oncogenic feature of IGF2-miR-483 loss of imprinting in hepatic cancer cells
por: Gailhouste, Luc, et al.
Publicado: (2019) -
A robust screening method for dietary agents that activate tumour-suppressor microRNAs
por: Hagiwara, Keitaro, et al.
Publicado: (2015) -
MicroRNA‐493‐5p‐mediated repression of the MYCN oncogene inhibits hepatic cancer cell growth and invasion
por: Yasukawa, Ken, et al.
Publicado: (2020)